<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.2?><?ConverterInfo.XSLTName jats2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Medicine (Baltimore)</journal-id><journal-id journal-id-type="iso-abbrev">Medicine (Baltimore)</journal-id><journal-id journal-id-type="publisher-id">MD</journal-id><journal-title-group><journal-title>Medicine</journal-title></journal-title-group><issn pub-type="ppub">0025-7974</issn><issn pub-type="epub">1536-5964</issn><publisher><publisher-name>Lippincott Williams &#x00026; Wilkins</publisher-name><publisher-loc>Hagerstown, MD</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmcid">12040010</article-id><article-id pub-id-type="pmid">40295272</article-id>
<article-id pub-id-type="publisher-id">MD-D-24-08638</article-id><article-id pub-id-type="art-access-id">00045</article-id><article-id pub-id-type="doi">10.1097/MD.0000000000042125</article-id><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" article-version-type="Version of Record">3</article-version><article-categories><subj-group subj-group-type="heading"><subject>4900</subject></subj-group><subj-group><subject>Research Article</subject><subject>Clinical Case Report</subject></subj-group></article-categories><title-group><article-title>
<italic toggle="yes">Cryptococcus albidus</italic> meningitis: A case report and literature review</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Genzhu</given-names></name><degrees>PhD</degrees><email>phoebejasmine@hotmail.com</email><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Hang</given-names></name><degrees>MS</degrees><email>895863363@qq.com</email><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Xiaoying</given-names></name><degrees>PhD</degrees><email>phoebejasmine@hotmail.com</email><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-0382-3136</contrib-id><name><surname>Li</surname><given-names>Zhongdong</given-names></name><degrees>PhD</degrees><xref rid="aff1" ref-type="aff">a</xref><xref rid="c1" ref-type="corresp">*</xref></contrib><aff id="aff1"><label>a</label> Beijing Electric Power Hospital of State Grid Co. of China, Capital Medical University Electric Teaching Hospital, Beijing, China.</aff></contrib-group><author-notes><corresp id="c1"><label>*</label>Correspondence: Zhongdong Li, Capital Medical University Electric Teaching Hospital, No. 1 Taipingqiao West Road, Beijing 100073, China (e-mail: <email xlink:href="zhdl009@126.com">zhdl009@126.com</email>).</corresp></author-notes><pub-date pub-type="collection"><day>25</day><month>4</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>25</day><month>4</month><year>2025</year></pub-date><volume>104</volume><issue>17</issue><elocation-id>e42125</elocation-id><history><date date-type="received"><day>06</day><month>8</month><year>2024</year></date><date date-type="accepted"><day>19</day><month>11</month><year>2024</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025 the Author(s). Published by Wolters Kluwer Health, Inc.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License 4.0 (CCBY)</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="medi-104-e42125.pdf"/><abstract><sec><title>Rationale:</title><p>Central nervous system (CNS) infections caused by <italic toggle="yes">Cryptococcus albidus</italic> are rarely reported, but are often associated with high mortality rates. Clinical data on the appropriate use of liposomal-amphotericin B (liposomal-AmB) with cryptococcal meningitis are limited. Here, we report for the first time the efficacious and safe use of the ideal bodyweight to calculate the dose of liposomal-AmB for a severely obese patient with <italic toggle="yes">C albidus</italic> meningitis. We also review the cases of CNS infection caused by <italic toggle="yes">C albidus</italic> and its related species.</p></sec><sec><title>Patient concerns:</title><p>A severely obese female patient was admitted to neurosurgical ward with lesions in the intracranial space and accompanying headache. Brain magnetic resonance imaging revealed prominent lesions in the right parietal and left frontal insular region. After glioma resection, <italic toggle="yes">C albidus</italic> was isolated from her cerebrospinal fluid samples.</p></sec><sec><title>Diagnoses, interventions, and outcomes:</title><p>She diagnosed histopathologically with a <italic toggle="yes">Cryptococcus</italic> species infection. The culture from her cerebrospinal fluid sample showed the growth of yeast-like colonies, which were identified as <italic toggle="yes">C albidus</italic> with mass spectrometry. She was treated with liposomal-AmB (50&#x02009;mg day<sup>-1</sup> intravenously) plus 5-fluorocytosine (10&#x02009;g day<sup>-1</sup> orally in 4 divided doses) for 6 weeks. The patient was asymptomatic at the time of discharge.</p></sec><sec><title>Lessons:</title><p>CNS infections of <italic toggle="yes">C albidus</italic> were uncommon. Using ideal bodyweight to calculate the dose of liposomal-AmB should be considered for severely obese patients with <italic toggle="yes">C albidus</italic> meningitis.</p></sec></abstract><kwd-group><kwd>case report</kwd><kwd>central nervous system infection</kwd><kwd>cryptococcal meningitis</kwd><kwd><italic toggle="yes">Cryptococcus albidus</italic></kwd><kwd>liposomal-amphotericin B</kwd><kwd>review</kwd></kwd-group><funding-group><award-group id="ID0E1BAE125858"><funding-source>Beijing Electric Power Hospital Doctoral Fund Project</funding-source><award-id>2022001</award-id><principal-award-recipient>Genzhu Wang</principal-award-recipient></award-group><award-group id="ID0ESDAE125859"><funding-source><institution-wrap><institution>Natural Science Foundation of Beijing Municipality</institution><institution-id institution-id-type="doi">10.13039/501100004826</institution-id></institution-wrap></funding-source><award-id>7234407</award-id><principal-award-recipient>Genzhu Wang</principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>OPEN-ACCESS</meta-name><meta-value>TRUE</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>1. Introduction</title><p>Central nervous system (CNS) infections of <italic toggle="yes">Cryptococcus</italic> species are life-threatening diseases. <italic toggle="yes">C albidus</italic>, also called <italic toggle="yes">Naganishia albida</italic>, was first reported to infect humans in 1965,<sup>[<xref rid="R1" ref-type="bibr">1</xref>]</sup> and several opportunistic infections associated with <italic toggle="yes">C albidus</italic> have since been reported.<sup>[<xref rid="R2" ref-type="bibr">2</xref>&#x02013;<xref rid="R4" ref-type="bibr">4</xref>]</sup> To date, the yeast has been isolated from the cerebrospinal fluid (CSF), lung abscesses, pleural fluids, and blood specimens of patients.<sup>[<xref rid="R5" ref-type="bibr">5</xref>]</sup> Of those invasive infections, 30% of the patients had a CNS infections.<sup>[<xref rid="R6" ref-type="bibr">6</xref>]</sup> Most notably, the mortality rate was 67% in patients with CNS infections caused by <italic toggle="yes">C albidus</italic>, which is more than double that of patients infected with other <italic toggle="yes">Cryptococcus</italic> species.<sup>[<xref rid="R6" ref-type="bibr">6</xref>]</sup> Although fewer than 10 cases of <italic toggle="yes">C albidus</italic> infection have been reported,<sup>[<xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R7" ref-type="bibr">7</xref>]</sup> the fungus has received attention because its mortality rate is high. Here, we report a clinical case of cryptococcal meningitis caused by <italic toggle="yes">C albidus</italic>. Clinically isolated <italic toggle="yes">C albidus</italic> may include many other related species, for example, <italic toggle="yes">C adeliensis</italic> and <italic toggle="yes">C diffluent</italic>.<sup>[<xref rid="R8" ref-type="bibr">8</xref>]</sup> No clear-cut epidemiological markers have been described to determine the likelihood of <italic toggle="yes">C albidus</italic>. Recommended guidelines for its treatment are also lacking. Therefore, it is extremely important to identify the risk factors, clinical presentation, diagnosis, and treatment for CNS infection due to <italic toggle="yes">C albidus</italic> and its related species.</p></sec><sec sec-type="cases"><title>2. Case presentation</title><p>A 25-year-old female patient (height was 158&#x02009;cm, bodyweight was 100&#x02009;kg) was admitted to Beijing Electric Power Hospital (Beijing, China) in March, 2022 with lesions in the intracranial space and accompanying headache. Six months before admission to the hospital, she had undergone successful left temporoparietal occipital craniotomy and decompressive craniectomy. Afterwards, she subsequently suffered intermittent headache, concurrently with nausea and disordered consciousness, and was treated with mannitol and levetiracetam before her admission. The patient denied any family or medical history, except invasive procedures of her CNS 6 months previously. She was a farmer, in frequent contact with cats and dogs. A physical examination revealed no unusual findings. Specifically, her body temperature was 36 &#x000b0;C, blood pressure 130/70&#x02009;mm Hg, pulse rate 68 beats/min, and respiratory rate 17 breaths/min. Brain magnetic resonance imaging revealed prominent lesions in the right parietal accompanied by moderate edema and left frontal insular region with mild edema. The lesion volume in the right parietal region and the left frontal insular was about 4&#x02005;&#x000d7;&#x02005;4&#x02005;&#x000d7;&#x02005;3&#x02009;cm<sup>3</sup> and 3&#x02005;&#x000d7;&#x02005;3&#x02005;&#x000d7;&#x02005;3&#x02009;cm<sup>3</sup>, respectively (Fig. <xref rid="F1" ref-type="fig">1</xref>).</p><fig position="float" id="F1"><label>Figure 1.</label><caption><p>Brain magnetic resonance imaging (MRI) scan of the patient before surgery. A type of circular lesion was observed in the right parietal lobe with long signals on T1-weighted (A) and T2-weighted (B) images. The lesion was about 4&#x02005;&#x000d7;&#x02005;4&#x02005;&#x000d7;&#x02005;3&#x02009;cm<sup>3</sup> in size (red arrow) and accompanied by moderate edema of surrounding brain tissue (yellow arrow). Another type of circular lesion was deep in the left frontal lobe, with long signals on T1-weighted (A) and T2-weighted (B) images. The lesion was about 3&#x02005;&#x000d7;&#x02005;3&#x02005;&#x000d7;&#x02005;3&#x02009;cm<sup>3</sup> in size (red arrow) and accompanied by mild edema (yellow arrow). Enhanced MRI scanning showed that the lesions were unevenly and significantly enhanced (C).</p></caption><graphic xlink:href="medi-104-e42125-g001" position="float"/></fig><p>On day 0 (admission), the patient&#x02019;s associated laboratory data were normal. Specifically, her white blood cell count was 9.5&#x02005;&#x000d7;&#x02005;10<sup>9</sup> L<sup>-1</sup>; neutrophils, lymphocytes, and monocytes accounted for 73.8%, 21.1%, and 4.9%, respectively. Her red blood cell count was 4.4&#x02005;&#x000d7;&#x02005;10<sup>12</sup> L<sup>-1</sup>, hemoglobin level was 133.0&#x02009;g L<sup>-1</sup>, and platelet count was 213.0&#x02005;&#x000d7;&#x02005;10<sup>9</sup> L<sup>-1</sup>. Urinalysis, hepatic and renal function tests were normal. During hospitalization, no chemotherapy and/or other immunosuppressive drug was administered. On day 5 after admission, the patient underwent right parieto-occipital for glioma resection. However, her headache persisted.</p><p>In the postoperative period, the patient experienced seizures, treated with mannitol and valproic acid. On day 14, she was diagnosed histopathologically with a <italic toggle="yes">Cryptococcus</italic> species infection. On day 16, the culture from her CSF sample showed the growth of yeast-like colonies, which were identified as <italic toggle="yes">C albidus</italic> with VITEK mass spectrometry (BioMerieux, France). To date, no Clinical and Laboratory Standards Institute clinical breakpoints or epidemiological cutoff values have been established for <italic toggle="yes">C albidus</italic>. The susceptibility of the pathogen to 5 antifungal compounds was tested in accordance with the guidelines of Clinical and Laboratory Standards Institute document M27-A3.<sup>[<xref rid="R9" ref-type="bibr">9</xref>]</sup> The minimal inhibitory concentrations of amphotericin B (AmB), fluconazole, voriconazole, itraconazole, and 5-fluorocytosine for <italic toggle="yes">C albidus</italic> were determined to be 0.5, 4, 1, 0.125, and 4&#x02009;mg L<sup>-1</sup>, respectively.</p><p>After the patient was diagnosed with a <italic toggle="yes">Cryptococcus</italic> species infection, she was administered with of liposomal-AmB (50&#x02009;mg day<sup>-1</sup> intravenously) qd plus 5-fluorocytosine (10&#x02009;g day<sup>-1</sup> orally in 4 divided doses) for 6 weeks. Her magnetic resonance imaging results showed that only the left frontal insular region still had a lesion, with otherwise normal parenchyma, after 3 weeks of treatment (Fig. <xref rid="F2" ref-type="fig">2</xref>). In addition, no yeast was isolated from 3 different CSF samples after 4 weeks of treatment (Table <xref rid="T1" ref-type="table">1</xref>). The patient maintained normal renal function during the entire treatment period (Fig. <xref rid="F3" ref-type="fig">3</xref>). On day 48 after admission, the patient stopped complaining of headache, and suffered no further nausea or consciousness disorder. The patient was asymptomatic at the time of discharge, with normal glucose, protein, and lactate levels in the CSF.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Analysis of cerebrospinal fluid.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">Hospitalization days</th><th align="center" rowspan="1" colspan="1">Glucose</th><th align="center" rowspan="1" colspan="1">Chloride</th><th align="center" rowspan="1" colspan="1">Microalbumin</th><th align="center" rowspan="2" colspan="1">Color</th><th align="center" rowspan="2" colspan="1">Turbidity</th><th align="center" rowspan="2" colspan="1">Pandy test</th><th align="center" rowspan="1" colspan="1">Red blood cells</th><th align="center" rowspan="1" colspan="1">White blood cells</th><th align="center" rowspan="1" colspan="1">Neutrophil</th><th align="center" rowspan="1" colspan="1">Lymphocyte</th><th align="center" rowspan="2" colspan="1">Culture</th></tr><tr><th align="center" rowspan="1" colspan="1">mmol/L</th><th align="center" rowspan="1" colspan="1">mmol/L</th><th align="center" rowspan="1" colspan="1">mg/L</th><th align="center" rowspan="1" colspan="1">/mm<sup>3</sup></th><th align="center" rowspan="1" colspan="1">/mm<sup>3</sup></th><th align="center" rowspan="1" colspan="1">%</th><th align="center" rowspan="1" colspan="1">%</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">3/16</td><td align="center" rowspan="1" colspan="1">2.88</td><td align="center" rowspan="1" colspan="1">118.2</td><td align="center" rowspan="1" colspan="1">80</td><td align="center" rowspan="1" colspan="1">Colorless</td><td align="center" rowspan="1" colspan="1">Clear</td><td align="center" rowspan="1" colspan="1">Positive</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">106</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">78</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">3/21</td><td align="center" rowspan="1" colspan="1">2.32</td><td align="center" rowspan="1" colspan="1">123</td><td align="center" rowspan="1" colspan="1">95</td><td align="center" rowspan="1" colspan="1">Colorless</td><td align="center" rowspan="1" colspan="1">Slightly turbid</td><td align="center" rowspan="1" colspan="1">Positive</td><td align="center" rowspan="1" colspan="1">1000</td><td align="center" rowspan="1" colspan="1">339</td><td align="center" rowspan="1" colspan="1">64</td><td align="center" rowspan="1" colspan="1">36</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">3/22</td><td align="center" rowspan="1" colspan="1">2.09</td><td align="center" rowspan="1" colspan="1">114.4</td><td align="center" rowspan="1" colspan="1">133</td><td align="center" rowspan="1" colspan="1">Red</td><td align="center" rowspan="1" colspan="1">Turbid</td><td align="center" rowspan="1" colspan="1">Positive</td><td align="center" rowspan="1" colspan="1">56,000</td><td align="center" rowspan="1" colspan="1">1196</td><td align="center" rowspan="1" colspan="1">46</td><td align="center" rowspan="1" colspan="1">54</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">C albidus</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">3/30</td><td align="center" rowspan="1" colspan="1">2.22</td><td align="center" rowspan="1" colspan="1">129.1</td><td align="center" rowspan="1" colspan="1">59</td><td align="center" rowspan="1" colspan="1">Colorless</td><td align="center" rowspan="1" colspan="1">Slightly turbid</td><td align="center" rowspan="1" colspan="1">Slightly positive</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">104</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">75</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">4/03</td><td align="center" rowspan="1" colspan="1">4.07</td><td align="center" rowspan="1" colspan="1">130.2</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">Colorless</td><td align="center" rowspan="1" colspan="1">Clear</td><td align="center" rowspan="1" colspan="1">Positive</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">149</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">99</td><td align="center" rowspan="1" colspan="1">Negative</td></tr><tr><td align="left" rowspan="1" colspan="1">4/19</td><td align="center" rowspan="1" colspan="1">3.99</td><td align="center" rowspan="1" colspan="1">127.6</td><td align="center" rowspan="1" colspan="1">46</td><td align="center" rowspan="1" colspan="1">Colorless</td><td align="center" rowspan="1" colspan="1">Clear</td><td align="center" rowspan="1" colspan="1">Negative</td><td align="center" rowspan="1" colspan="1">1000</td><td align="center" rowspan="1" colspan="1">136</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">98</td><td align="center" rowspan="1" colspan="1">Negative</td></tr><tr><td align="left" rowspan="1" colspan="1">4/21</td><td align="center" rowspan="1" colspan="1">4.05</td><td align="center" rowspan="1" colspan="1">132.1</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">Colorless</td><td align="center" rowspan="1" colspan="1">Clear</td><td align="center" rowspan="1" colspan="1">Negative</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">96</td><td align="center" rowspan="1" colspan="1">Negative</td></tr></tbody></table></table-wrap><fig position="float" id="F2"><label>Figure 2.</label><caption><p>MRI scan of the patient after surgery. The lesion in the right parietal lobe was resected, whereas the lesion in the left frontal lobe (red arrow) was still observed with long signals on T1-weighted (A) and T2-weighted (B) images. Enhanced MRI scanning showed that the lesion was only mildly enhanced after treatment (C).</p></caption><graphic xlink:href="medi-104-e42125-g002" position="float"/></fig><fig position="float" id="F3"><label>Figure 3.</label><caption><p>Renal function of the patient. Adjusted creatinine clearance rate (Ccr) was calculated with the following equation: Ccr (mL/min)&#x02005;=&#x02005;(146&#x02005;-&#x02005;age)&#x02005;&#x000d7;&#x02005;(0.287&#x02005;&#x000d7;&#x02005;weight [kg]&#x02005;+&#x02005;9.74&#x02005;&#x000d7;&#x02005;height<sup>2</sup> [m]<sup>2</sup>)/ (60&#x02005;&#x000d7;&#x02005;serum creatinine[mg/dL]). BUN = blood urea nitrogen, Scr = serum creatinine.</p></caption><graphic xlink:href="medi-104-e42125-g003" position="float"/></fig></sec><sec sec-type="discussion"><title>3. Discussion</title><p><italic toggle="yes">C albidus</italic> in the genus <italic toggle="yes">Cryptococcus</italic>, is a rare species that causes cryptococcal infections, especially in the CNS infections. The antifungal treatment recommended for cryptococcal meningoencephalitis is liposomal-AmB plus flucytosine.<sup>[<xref rid="R10" ref-type="bibr">10</xref>,<xref rid="R11" ref-type="bibr">11</xref>]</sup> Although liposomal-AmB has been used for several decades, little is known about its pharmacokinetics in obese patients.<sup>[<xref rid="R12" ref-type="bibr">12</xref>,<xref rid="R13" ref-type="bibr">13</xref>]</sup> The prescribing information for cryptococcal disease recommends weight-based doses of 0.7 to 6&#x02009;mg/kg/day AmB, depending upon the AmB product used. To date, the calculation of the appropriate dose for severely obese patients is controversial.<sup>[<xref rid="R13" ref-type="bibr">13</xref>,<xref rid="R14" ref-type="bibr">14</xref>]</sup> Animal studies have demonstrated significantly increased AmB serum concentrations and increased rates of nephrotoxicity in obese rats and rabbits, with poor distribution of adipose tissue.<sup>[<xref rid="R15" ref-type="bibr">15</xref>]</sup> Furthermore, women have a higher body fat rate than men, which is a risk factor for acute kidney injury caused by liposomal-AmB.<sup>[<xref rid="R16" ref-type="bibr">16</xref>]</sup> Therefore, it may be reasonable to consider the ideal bodyweight rather than the actual bodyweight when calculating the dose of liposomal-AmB for severely obese female patients. In this case, we have demonstrated the efficacy and safety of using the ideal bodyweight, rather than the actual bodyweight, to calculate the dose of liposomal-AmB for a severely obese patient with <italic toggle="yes">C albidus</italic> meningitis.</p><p>A comprehensive review of the literature was performed in accordance with the &#x0201c;Preferred Reporting Items for Systematic Reviews and Meta-Analysis.&#x0201d;<sup>[<xref rid="R17" ref-type="bibr">17</xref>&#x02013;<xref rid="R19" ref-type="bibr">19</xref>]</sup> Studies of case report relevant to CNS infections attributed to <italic toggle="yes">C albidus</italic> and its related species in the PubMed, Medline, and Web of Science databases from their inception until July 2024. The following key words were used: fungus, human infection, CNS, meningitis, ventriculitis, encephalitis, non-neoformans, cryptococcus, naganishia, adeliensis, albida, albidus, chernovii, curvatus, diffluens, friedmannii, liquefaciens, magnus, terreus, uniguttulatus, and uzbekitanensis. The references in each manuscript were also reviewed to identify additional cases.</p><p>Our searches yielded 104 potentially relevant records. After nonhuman species (e.g., dog, cat, pigeon) were excluded,<sup>[<xref rid="R20" ref-type="bibr">20</xref>,<xref rid="R21" ref-type="bibr">21</xref>]</sup> 86 studies were included. After non-CNS cases, non-research studies, non-<italic toggle="yes">Cryptococcus, C neoformans</italic> species complex, and <italic toggle="yes">C gattii</italic> species complex infections were excluded,<sup>[<xref rid="R10" ref-type="bibr">10</xref>,<xref rid="R22" ref-type="bibr">22</xref>&#x02013;<xref rid="R28" ref-type="bibr">28</xref>]</sup> 17 studies were reported. Of those 17 studies, 7 were cohort studies of <italic toggle="yes">Cryptococcus</italic>,<sup>[<xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R29" ref-type="bibr">29</xref>&#x02013;<xref rid="R34" ref-type="bibr">34</xref>]</sup> and 1 study was of <italic toggle="yes">C laurentii</italic> meningitis combined with <italic toggle="yes">C albidus</italic> cryptococcaemia.<sup>[<xref rid="R35" ref-type="bibr">35</xref>]</sup> Finally, 9 cases of CNS infections caused by <italic toggle="yes">C albidus</italic> or its related species have been reported. The risk factors, manifestations, diagnosis, and treatment for these pathogens are presented in table <xref rid="T2" ref-type="table">2</xref>. Like other <italic toggle="yes">Cryptococcus</italic> species, <italic toggle="yes">C albidus</italic> and its related species were commonly isolated from the gastrointestinal tracts and droppings of birds.<sup>[<xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R36" ref-type="bibr">36</xref>]</sup> There is, as yet, no explanation of how humans contract these infections. Reasons may include the worldwide increase in immunocompromised patients, the widespread use of immunosuppressive agents, and the prolonged use of central venous catheters or indwelling devices.<sup>[<xref rid="R9" ref-type="bibr">9</xref>]</sup> In our systematic review of the literature, we detected 2 cases of infection in human immunodeficiency virus (HIV) infected adults and 4 in apparently immunodeficient individuals.<sup>[<xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R38" ref-type="bibr">38</xref>]</sup> Leukemia and cancer are important risk factors in HIV-negative patients.<sup>[<xref rid="R36" ref-type="bibr">36</xref>,<xref rid="R37" ref-type="bibr">37</xref>,<xref rid="R39" ref-type="bibr">39</xref>]</sup> The administration of corticosteroids agents, exposure to bird excrement, contact with animals, and surgery are also risk factors for these infections.<sup>[<xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R36" ref-type="bibr">36</xref>]</sup></p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Summary of data from central nervous system infection caused by <italic toggle="yes">C albidus</italic> and its related species in humans.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Author, year</th><th align="center" rowspan="1" colspan="1">Country</th><th align="center" rowspan="1" colspan="1">Age/gender</th><th align="center" rowspan="1" colspan="1">Potential risk factors</th><th align="center" rowspan="1" colspan="1">Manifestation</th><th align="center" rowspan="1" colspan="1">Duration of symptoms</th><th align="center" rowspan="1" colspan="1"><italic toggle="yes">Cryptococcus</italic> species</th><th align="center" rowspan="1" colspan="1">Taxonomical identification methods</th><th align="center" rowspan="1" colspan="1">Treatment</th><th align="center" rowspan="1" colspan="1">Outcomes</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">da Cunha Lusins (1973)<sup>[<xref rid="R2" ref-type="bibr">2</xref>]</sup></td><td align="center" rowspan="1" colspan="1">New York, USA</td><td align="center" rowspan="1" colspan="1">45/M</td><td align="center" rowspan="1" colspan="1">Exposure to pigeon excrement</td><td align="center" rowspan="1" colspan="1">Meningitis, headache, nausea and vomiting</td><td align="center" rowspan="1" colspan="1">3 days</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">C albidus</italic>
</td><td align="center" rowspan="1" colspan="1">Culture</td><td align="center" rowspan="1" colspan="1">AmB (1500&#x02009;mg)</td><td align="center" rowspan="1" colspan="1">Cured</td></tr><tr><td align="left" rowspan="1" colspan="1">Melo et al (1980)<sup>[<xref rid="R3" ref-type="bibr">3</xref>]</sup></td><td align="center" rowspan="1" colspan="1">Kentucky</td><td align="center" rowspan="1" colspan="1">29/M</td><td align="center" rowspan="1" colspan="1">Mentally retarded, receiving corticosteroids agents, surgery</td><td align="center" rowspan="1" colspan="1">Meningitis, headache</td><td align="center" rowspan="1" colspan="1">2 weeks</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">C albidus</italic>
</td><td align="center" rowspan="1" colspan="1">Culture</td><td align="center" rowspan="1" colspan="1">AmB</td><td align="center" rowspan="1" colspan="1">Died</td></tr><tr><td align="left" rowspan="1" colspan="1">McCurdy et al (2001)<sup>[<xref rid="R36" ref-type="bibr">36</xref>]</sup></td><td align="center" rowspan="1" colspan="1">Nashville, USA</td><td align="center" rowspan="1" colspan="1">65/F</td><td align="center" rowspan="1" colspan="1">Ovarian cancer, invasive neurosurgical procedure</td><td align="center" rowspan="1" colspan="1">Ventriculitis, headache and mental status changes.</td><td align="center" rowspan="1" colspan="1">1 day</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">C uniguttulatus</italic>
</td><td align="center" rowspan="1" colspan="1">Culture and ID 20C</td><td align="center" rowspan="1" colspan="1">AmB (0.6&#x02009;mg/kg)&#x02005;+&#x02005;5-FU</td><td align="center" rowspan="1" colspan="1">Cured</td></tr><tr><td align="left" rowspan="1" colspan="1">Rimek et al (2004)<sup>[<xref rid="R37" ref-type="bibr">37</xref>]</sup></td><td align="center" rowspan="1" colspan="1">Germany</td><td align="center" rowspan="1" colspan="1">40/F</td><td align="center" rowspan="1" colspan="1">Acute myeloid leukemia, peripheral blood stem cell transplantation and central venous catheter</td><td align="center" rowspan="1" colspan="1">Meningitis, fever, headache and paraparesis</td><td align="center" rowspan="1" colspan="1">4 days</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">C adeliensis</italic>
</td><td align="center" rowspan="1" colspan="1">Culture, ID 32C and ITS D1/D2 Sequencing</td><td align="center" rowspan="1" colspan="1">Liposomal-AmB (5&#x02009;mg/kg)&#x02005;+&#x02005;AmB (0.25&#x02009;mg intrathecally biw)&#x02005;+&#x02005;5-FU (120&#x02009;mg/kg)</td><td align="center" rowspan="1" colspan="1">Died</td></tr><tr><td align="left" rowspan="1" colspan="1">Pan et al (2011)<sup>[<xref rid="R9" ref-type="bibr">9</xref>]</sup></td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">37/M</td><td align="center" rowspan="1" colspan="1">Low CD4 lymphocyte count</td><td align="center" rowspan="1" colspan="1">Meningitis, fever, cough, vomiting and headache</td><td align="center" rowspan="1" colspan="1">15 days</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">C uniguttulatus</italic>
</td><td align="center" rowspan="1" colspan="1">Culture and ITS D1/D2 Sequencing</td><td align="center" rowspan="1" colspan="1">AmB (0.7&#x02009;mg/kg)&#x02005;+&#x02005;5-FU (100&#x02009;mg/kg qid)</td><td align="center" rowspan="1" colspan="1">Cured</td></tr><tr><td align="left" rowspan="1" colspan="1">Liu et al (2013)<sup>[<xref rid="R7" ref-type="bibr">7</xref>]</sup></td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">28/M</td><td align="center" rowspan="1" colspan="1">AIDS</td><td align="center" rowspan="1" colspan="1">Encephalitis, diplopia, vomiting, tinnitus, neck stiffness, strabism and vertigo.</td><td align="center" rowspan="1" colspan="1">2 weeks</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">C albidus</italic>
</td><td align="center" rowspan="1" colspan="1">Culture</td><td align="center" rowspan="1" colspan="1">Fluconazole (NA)</td><td align="center" rowspan="1" colspan="1">Died</td></tr><tr><td align="left" rowspan="1" colspan="1">Conde-Pereira et al (2015)<sup>[<xref rid="R38" ref-type="bibr">38</xref>]</sup></td><td align="center" rowspan="1" colspan="1">Guatemala</td><td align="center" rowspan="1" colspan="1">31/F</td><td align="center" rowspan="1" colspan="1">AIDS</td><td align="center" rowspan="1" colspan="1">Meningitis, headache, vomiting, fever, asthenia and adynamia</td><td align="center" rowspan="1" colspan="1">1 month</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">C liquefaciens</italic>
</td><td align="center" rowspan="1" colspan="1">Culture, ID 32C, MALDI-TOF MS and ITS D1/D2 Sequencing</td><td align="center" rowspan="1" colspan="1">AmB deoxycholate (0.7&#x02009;mg/kg)</td><td align="center" rowspan="1" colspan="1">Died</td></tr><tr><td align="left" rowspan="1" colspan="1">Animalu et al (2015)<sup>[<xref rid="R39" ref-type="bibr">39</xref>]</sup></td><td align="center" rowspan="1" colspan="1">Memphis, USA</td><td align="center" rowspan="1" colspan="1">72/F</td><td align="center" rowspan="1" colspan="1">Non-small-cell lung carcinoma</td><td align="center" rowspan="1" colspan="1">Meningitis, headache, nausea and emesis</td><td align="center" rowspan="1" colspan="1">unknown</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">C uniguttulatus</italic>
</td><td align="center" rowspan="1" colspan="1">Culture and ID 20C</td><td align="center" rowspan="1" colspan="1">Liposomal-AmB (5&#x02009;mg/kg)&#x02005;+&#x02005;fluconazole (400&#x02009;mg bid)&#x02192; voriconazole</td><td align="center" rowspan="1" colspan="1">Cured</td></tr><tr><td align="left" rowspan="1" colspan="1">Present case</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">25/F</td><td align="center" rowspan="1" colspan="1">Glioma, surgery</td><td align="center" rowspan="1" colspan="1">Meningitis, headache, vomiting and nausea</td><td align="center" rowspan="1" colspan="1">6 months</td><td align="center" rowspan="1" colspan="1">
<italic toggle="yes">C albidus</italic>
</td><td align="center" rowspan="1" colspan="1">Culture and VITEK MS</td><td align="center" rowspan="1" colspan="1">Liposomal Amp B (50&#x02009;mg qd)&#x02005;+&#x02005;5-FU (100&#x02009;mg/kg qid)</td><td align="center" rowspan="1" colspan="1">Cured</td></tr></tbody></table><table-wrap-foot><fn fn-type="other"><p>&#x02192; = change to, AIDS&#x02005;=&#x02005;acquired immunodeficiency syndrome, AmB&#x02005;=&#x02005;amphotericin B, F = female, 5-FU = fluconazole, ITS&#x02005;=&#x02005;internal transcribed space, M = male, MALDI-TOF MS = matrix-assisted laser desorption ionization-time of flight mass spectrometry, MS = mass spectrometry.</p></fn></table-wrap-foot></table-wrap><p>Patients can present with headache, fever, altered mental state, nausea, and vomiting. Headache is the commonest symptom, and only 1 patient reported no headache.<sup>[<xref rid="R7" ref-type="bibr">7</xref>]</sup> Although fever is possible, it only presented in 3 cases (31%). These results are similar to a cohort study that showed fever present in 28% of cases.<sup>[<xref rid="R29" ref-type="bibr">29</xref>]</sup> Patients also presented with increased intracranial pressure increasing and altered mental states, and these neurological symptoms are similar to other cryptococcal infections.<sup>[<xref rid="R28" ref-type="bibr">28</xref>]</sup> The cryptococcal capsule lodges in the arachnoid villi and subsequently prevents CSF reabsorption may explain the elevated intracranial pressure.<sup>[<xref rid="R40" ref-type="bibr">40</xref>]</sup></p><p>Culture and API&#x000ae; strip assimilation test are laboratory commonly used methods to identify isolated <italic toggle="yes">Cryptococcus</italic> species.<sup>[<xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R38" ref-type="bibr">38</xref>,<xref rid="R39" ref-type="bibr">39</xref>]</sup> However, it may be difficult to identify species when only 1 or 2 methods are used. Without the sequence of the D1/D2 domains of the large-subunit of ribosomal RNA (rRNA), some rare <italic toggle="yes">Cryptococcus</italic> species can be misidentified as <italic toggle="yes">C albidus</italic>.<sup>[<xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R27" ref-type="bibr">27</xref>,<xref rid="R41" ref-type="bibr">41</xref>]</sup> For example, a yeast isolate was initially identified as <italic toggle="yes">C albidus</italic> with an API&#x000ae; strip assimilation test. However, after the internal transcribed spacer and the D1/D2 domains of the large-subunit rRNA were sequenced, the isolate was finally confirmed as <italic toggle="yes">C liquefaciens</italic>.<sup>[<xref rid="R38" ref-type="bibr">38</xref>]</sup> Mass spectrometry is a new methodology for identifying bacterial species, and some studies have shown that the accuracy of mass spectrometry for their identification is over 95% at the species level.<sup>[<xref rid="R42" ref-type="bibr">42</xref>&#x02013;<xref rid="R44" ref-type="bibr">44</xref>]</sup> Hence, the identification of <italic toggle="yes">C albidus</italic> based on VITEK mass spectrometry is reliable.</p><p>Because these fungi are infrequent causes of disease, there are no evidence-based guidelines or standard recommendations for their treatment. The susceptibility of <italic toggle="yes">C albidus</italic> and its related species to antifungal agents is shown in Table <xref rid="T3" ref-type="table">3</xref>. The cumulative experience reported in the published literature suggests that AmB is the only agent to which <italic toggle="yes">C albidus</italic> and its related species are consistently sensitive.<sup>[<xref rid="R45" ref-type="bibr">45</xref>,<xref rid="R46" ref-type="bibr">46</xref>]</sup> Therefore, AmB is a safe and effective drug for use as initial induction therapy against these infections in the CNS. However, consideration should be given henceforth to submitting these clinical isolates for susceptibility testing and proper identification to guide subsequent therapeutic decisions. To date, no randomized controlled trials have been conducted to optimize the choice of AmB or the duration of its therapy. We recommend: (1) using liposomal-AmB instead of AmB deoxycholate because liposomal-AmB is safer and more rapidly sterilizes the CSF than AmB deoxycholate<sup>[<xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R12" ref-type="bibr">12</xref>,<xref rid="R32" ref-type="bibr">32</xref>]</sup>; (2) at least 1&#x02009;g of AmB during treatment and prolonged treatment are recommended.<sup>[<xref rid="R47" ref-type="bibr">47</xref>]</sup> (3) The combination of AmB and 5-fluorocytosine, is recommended because it has been shown to reduce the toxicity of this drug and reduce the relapse rate of <italic toggle="yes">C albidus</italic> infections.<sup>[<xref rid="R30" ref-type="bibr">30</xref>,<xref rid="R31" ref-type="bibr">31</xref>]</sup></p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Antifungal susceptibility of <italic toggle="yes">Cryptococcus</italic> species.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="3" colspan="1">Antifungal agents</th><th align="center" colspan="6" rowspan="1">Minimal inhibitory concentrations (&#x003bc;g/mL)</th></tr><tr><th align="center" rowspan="1" colspan="1">McCurdy et al (2001)</th><th align="center" rowspan="1" colspan="1">Rimek et al (2004)</th><th align="center" rowspan="1" colspan="1">Pan et al (2011)</th><th align="center" rowspan="1" colspan="1">Conde-Pereira et al (2015)</th><th align="center" rowspan="1" colspan="1">Animalu et al (2015)</th><th align="center" rowspan="1" colspan="1">Present case</th></tr><tr><th align="center" rowspan="1" colspan="1">
<italic toggle="yes">C uniguttulatus</italic>
<sup>[<xref rid="R36" ref-type="bibr">36</xref>]</sup>
</th><th align="center" rowspan="1" colspan="1">
<italic toggle="yes">C adeliensis</italic>
<sup>[<xref rid="R37" ref-type="bibr">37</xref>]</sup>
</th><th align="center" rowspan="1" colspan="1">
<italic toggle="yes">C uniguttulatum</italic>
<sup>[<xref rid="R9" ref-type="bibr">9</xref>]</sup>
</th><th align="center" rowspan="1" colspan="1">
<italic toggle="yes">C liquefaciens</italic>
<sup>[<xref rid="R38" ref-type="bibr">38</xref>]</sup>
</th><th align="center" rowspan="1" colspan="1">
<italic toggle="yes">C uniguttulatus</italic>
<sup>[<xref rid="R39" ref-type="bibr">39</xref>]</sup>
</th><th align="center" rowspan="1" colspan="1">
<italic toggle="yes">C albidus</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Amphotericin B</td><td align="center" rowspan="1" colspan="1">0.25</td><td align="center" rowspan="1" colspan="1">0.125</td><td align="center" rowspan="1" colspan="1">0.125</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x02264;0.12</td><td align="center" rowspan="1" colspan="1">0.5</td></tr><tr><td align="left" rowspan="1" colspan="1">5-Flucytosine</td><td align="center" rowspan="1" colspan="1">&#x0003e;64</td><td align="center" rowspan="1" colspan="1">&#x0003e;64</td><td align="center" rowspan="1" colspan="1">&#x0003e;64</td><td align="center" rowspan="1" colspan="1">&#x0003e;64</td><td align="center" rowspan="1" colspan="1">64</td><td align="center" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1">Fluconazole</td><td align="center" rowspan="1" colspan="1">&#x0003e;64</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">64</td><td align="center" rowspan="1" colspan="1">&#x0003e;256</td><td align="center" rowspan="1" colspan="1">128</td><td align="center" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1">Voriconazole</td><td align="center" rowspan="1" colspan="1">NG</td><td align="center" rowspan="1" colspan="1">0.25</td><td align="center" rowspan="1" colspan="1">0.5</td><td align="center" rowspan="1" colspan="1">&#x0003e;8</td><td align="center" rowspan="1" colspan="1">0.25</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Itraconazole</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0.25</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x0003e;16</td><td align="center" rowspan="1" colspan="1">0.5</td><td align="center" rowspan="1" colspan="1">0.125</td></tr><tr><td align="left" rowspan="1" colspan="1">Posaconazole</td><td align="center" rowspan="1" colspan="1">NG</td><td align="center" rowspan="1" colspan="1">NG</td><td align="center" rowspan="1" colspan="1">0.5</td><td align="center" rowspan="1" colspan="1">&#x0003e;8</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">NG</td></tr></tbody></table></table-wrap></sec><sec><title>4. Conclusion</title><p>Using the ideal bodyweight to calculate the appropriate dose of liposomal-AmB for obese patients with <italic toggle="yes">C albidus</italic> meningitis is both efficacious and safe. Based on the systematic review of CNS infections of <italic toggle="yes">C albidus</italic> and its related species, we also concluded that leukemia and cancer are important risk factors for these infections and that headache is the most frequent symptom. The identification of fungal pathogens requires the analysis the rRNA sequences because many species share phenotypic similarities. AmB-based treatment should be the first choice, and subsequent treatment should be guided by susceptibility testing.</p></sec><sec><title>Acknowledgments</title><p>We thank the patient for participating in this study. We thank International Science Editing (<ext-link xlink:href="http://www.internationalscienceediting.com" ext-link-type="uri">http://www.internationalscienceediting.com</ext-link>) for editing this manuscript. We thank Professor Yiyou Gu (The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California, USA) for review services and Professor Xiaorui Wang (Beijing Electric Power Hospital) for critical reading of the MRI scan results.</p></sec><sec><title>Author contributions</title><p><bold>Conceptualization:</bold> Zhongdong Li.</p><p><bold>Data curation:</bold> Hang Liu, Xiaoying Wang.</p><p><bold>Methodology:</bold> Hang Liu.</p><p><bold>Writing &#x02013; original draft:</bold> Genzhu Wang.</p><p><bold>Writing &#x02013; review &#x00026; editing:</bold> Xiaoying Wang, Zhongdong Li.</p></sec></body><back><fn-group><fn fn-type="abbr"><p><def-list><title>Abbreviations:</title><def-item><term>AmB</term><def><p>amphotericin B</p></def></def-item><def-item><term>C albidus</term><def><p>Cryptococcus albidus</p></def></def-item><def-item><term>CNS</term><def><p>central nervous system</p></def></def-item><def-item><term>CSF</term><def><p>cerebrospinal fluid,</p></def></def-item><def-item><term>rRNA</term><def><p>ribosomal RNA</p></def></def-item></def-list>
</p></fn></fn-group><fn-group><fn fn-type="financial-disclosure"><p>The authors declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by the Beijing Electric Power Hospital Doctoral Fund Project (No. B2022001) and the Beijing Natural Science Foundation (grant number: 7234407).</p></fn><fn fn-type="other"><p>Written informed consent for participation in this study was provided by the participants&#x02019; legal guardians/next of kin. Written informed consent was obtained from the individual for the publication of any potentially identifiable images or data included in this article.</p></fn><fn fn-type="other"><p>This study was approved by the ethics committee of Beijing Electric Power Hospital, State Grid Corporation of China (Ethics Number: KY-2021-018-01). The studies were conducted in accordance with the local legislation and institutional requirements.</p></fn><fn fn-type="other"><p>The authors have no conflicts of interest to disclose.</p></fn><fn fn-type="other"><p>The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.</p></fn><fn fn-type="other"><p>How to cite this article: Wang G, Liu H, Wang X, Li Z. <italic toggle="yes">Cryptococcus albidus</italic> meningitis: A case report and literature review. Medicine 2025;104:17(e42125).</p></fn><fn fn-type="other"><p>GW and HL contributed equally to this work.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>[1]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wieser</surname><given-names>HG</given-names></name></person-group>. <article-title>Pathogenicity of <italic toggle="yes">Crytococcus albidus</italic>.</article-title>
<source>Schweiz Med Wochenschr</source>. <year>1973</year>;<volume>103</volume>:<fpage>475</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="pmid">4572957</pub-id>
</mixed-citation></ref><ref id="R2"><label>[2]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Da Cunha</surname><given-names>T</given-names></name><name><surname>Lusins</surname><given-names>J</given-names></name></person-group>. <article-title><italic toggle="yes">Cryptococcus albidus</italic> meningitis.</article-title>
<source>South Med J</source>. <year>1973</year>;<volume>66</volume>:<fpage>1230 passim</fpage>.<pub-id pub-id-type="pmid">4745601</pub-id>
</mixed-citation></ref><ref id="R3"><label>[3]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melo</surname><given-names>JC</given-names></name><name><surname>Srinivasan</surname><given-names>S</given-names></name><name><surname>Scott</surname><given-names>ML</given-names></name><name><surname>Raff</surname><given-names>MJ</given-names></name></person-group>. <article-title><italic toggle="yes">Cryptococcus albidus</italic> meningitis.</article-title>
<source>J Infect</source>. <year>1980</year>;<volume>2</volume>:<fpage>79</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="pmid">7185917</pub-id>
</mixed-citation></ref><ref id="R4"><label>[4]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gluck</surname><given-names>JL</given-names></name><name><surname>Myers</surname><given-names>JP</given-names></name><name><surname>Pass</surname><given-names>LM</given-names></name></person-group>. <article-title>Cryptococcemia due to <italic toggle="yes">Cryptococcus albidus</italic>.</article-title>
<source>South Med J</source>. <year>1987</year>;<volume>80</volume>:<fpage>511</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="pmid">3470948</pub-id>
</mixed-citation></ref><ref id="R5"><label>[5]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khawcharoenporn</surname><given-names>T</given-names></name><name><surname>Apisarnthanarak</surname><given-names>A</given-names></name><name><surname>Mundy</surname><given-names>LM</given-names></name></person-group>. <article-title>Non-neoformans cryptococcal infections: a systematic review.</article-title>
<source>Infection</source>. <year>2007</year>;<volume>35</volume>:<fpage>51</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">17401707</pub-id>
</mixed-citation></ref><ref id="R6"><label>[6]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choe</surname><given-names>YJ</given-names></name><name><surname>Blatt</surname><given-names>DB</given-names></name><name><surname>Yalcindag</surname><given-names>A</given-names></name><name><surname>Geffert</surname><given-names>SF</given-names></name><name><surname>Bobenchik</surname><given-names>AM</given-names></name><name><surname>Michelow</surname><given-names>IC</given-names></name></person-group>. <article-title><italic toggle="yes">Cryptococcus albidus</italic> fungemia in an immunosuppressed child: case report and systematic literature review.</article-title>
<source>J. Pediatric Infect. Dis. Soc</source>.. <year>2020</year>;<volume>9</volume>:<fpage>100</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">31183496</pub-id>
</mixed-citation></ref><ref id="R7"><label>[7]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Tang</surname><given-names>J</given-names></name></person-group>. <article-title><italic toggle="yes">Cryptococcus albidus</italic> encephalitis in newly diagnosed HIV-patient and literature review.</article-title>
<source>Med Mycol Case Rep</source>. <year>2014</year>;<volume>3</volume>:<fpage>8</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="pmid">24567892</pub-id>
</mixed-citation></ref><ref id="R8"><label>[8]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fonseca</surname><given-names>A</given-names></name><name><surname>Scorzetti</surname><given-names>G</given-names></name><name><surname>Fell</surname><given-names>JW</given-names></name></person-group>. <article-title>Diversity in the yeast <italic toggle="yes">Cryptococcus albidus</italic> and related species as revealed by ribosomal DNA sequence analysis.</article-title>
<source>Can J Microbiol</source>. <year>2000</year>;<volume>46</volume>:<fpage>7</fpage>&#x02013;<lpage>27</lpage>.<pub-id pub-id-type="pmid">10696468</pub-id>
</mixed-citation></ref><ref id="R9"><label>[9]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>W</given-names></name><name><surname>Liao</surname><given-names>W</given-names></name><name><surname>Hagen</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Meningitis caused by <italic toggle="yes">Filobasidium uniguttulatum</italic>: case report and overview of the literature.</article-title>
<source>Mycoses</source>. <year>2012</year>;<volume>55</volume>:<fpage>105</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">21729175</pub-id>
</mixed-citation></ref><ref id="R10"><label>[10]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perfect</surname><given-names>JR</given-names></name><name><surname>Dismukes</surname><given-names>WE</given-names></name><name><surname>Dromer</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.</article-title>
<source>Clin Infect Dis</source>. <year>2010</year>;<volume>50</volume>:<fpage>291</fpage>&#x02013;<lpage>322</lpage>.<pub-id pub-id-type="pmid">20047480</pub-id>
</mixed-citation></ref><ref id="R11"><label>[11]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jarvis</surname><given-names>JN</given-names></name><name><surname>Lawrence</surname><given-names>DS</given-names></name><name><surname>Meya</surname><given-names>DB</given-names></name><etal/></person-group>. <article-title>Single-dose liposomal amphotericin B treatment for cryptococcal meningitis.</article-title>
<source>N Engl J Med</source>. <year>2022</year>;<volume>386</volume>:<fpage>1109</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="pmid">35320642</pub-id>
</mixed-citation></ref><ref id="R12"><label>[12]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stone</surname><given-names>NR</given-names></name><name><surname>Bicanic</surname><given-names>T</given-names></name><name><surname>Salim</surname><given-names>R</given-names></name><name><surname>Hope</surname><given-names>W</given-names></name></person-group>. <article-title>Liposomal Amphotericin B (AmBisome(&#x000ae;)): a review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions.</article-title>
<source>Drugs</source>. <year>2016</year>;<volume>76</volume>:<fpage>485</fpage>&#x02013;<lpage>500</lpage>.<pub-id pub-id-type="pmid">26818726</pub-id>
</mixed-citation></ref><ref id="R13"><label>[13]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wasmann</surname><given-names>RE</given-names></name><name><surname>Smit</surname><given-names>C</given-names></name><name><surname>Van Dongen</surname><given-names>EPH</given-names></name><etal/></person-group>. <article-title>Fixed dosing of liposomal amphotericin B in morbidly obese individuals.</article-title>
<source>Clin Infect Dis</source>. <year>2020</year>;<volume>70</volume>:<fpage>2213</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">31588493</pub-id>
</mixed-citation></ref><ref id="R14"><label>[14]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ting</surname><given-names>MH</given-names></name><name><surname>Spec</surname><given-names>A</given-names></name><name><surname>Micek</surname><given-names>ST</given-names></name><name><surname>Ritchie</surname><given-names>DJ</given-names></name><name><surname>Krekel</surname><given-names>T</given-names></name></person-group>. <article-title>Evaluation of total body weight versus adjusted body weight liposomal amphotericin B dosing in obese patients.</article-title>
<source>Antimicrob Agents Chemother</source>. <year>2021</year>;<volume>65</volume>:<fpage>e0236620</fpage>.<pub-id pub-id-type="pmid">34125591</pub-id>
</mixed-citation></ref><ref id="R15"><label>[15]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polso</surname><given-names>AK</given-names></name><name><surname>Lassiter</surname><given-names>JL</given-names></name><name><surname>Nagel</surname><given-names>JL</given-names></name></person-group>. <article-title>Impact of hospital guideline for weight-based antimicrobial dosing in morbidly obese adults and comprehensive literature review.</article-title>
<source>J Clin Pharm Ther</source>. <year>2014</year>;<volume>39</volume>:<fpage>584</fpage>&#x02013;<lpage>608</lpage>.<pub-id pub-id-type="pmid">25203631</pub-id>
</mixed-citation></ref><ref id="R16"><label>[16]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yongwu</surname><given-names>C</given-names></name><name><surname>Shengyu</surname><given-names>Z</given-names></name><name><surname>Xiaowen</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Risk factors analysis of liposomal amphotericin B-related acute kidney injury.</article-title>
<source>Herald Med</source>. <year>2021</year>;<volume>40</volume>:<fpage>416</fpage>.</mixed-citation></ref><ref id="R17"><label>[17]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>Long-acting versus short-acting granulocyte colony-stimulating factors among cancer patients after chemotherapy in China: a systematic review and meta-analysis of randomized controlled trials.</article-title>
<source>Medicine (Baltimore)</source>. <year>2021</year>;<volume>100</volume>:<fpage>e28218</fpage>.<pub-id pub-id-type="pmid">34941082</pub-id>
</mixed-citation></ref><ref id="R18"><label>[18]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Lin</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>The association between 5, 10 - methylenetetrahydrofolate reductase and the risk of unexplained recurrent pregnancy loss in China: a meta-analysis.</article-title>
<source>Medicine (Baltimore)</source>. <year>2021</year>;<volume>100</volume>:<fpage>e25487</fpage>.<pub-id pub-id-type="pmid">33907097</pub-id>
</mixed-citation></ref><ref id="R19"><label>[19]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moher</surname><given-names>D</given-names></name><name><surname>Shamseer</surname><given-names>L</given-names></name><name><surname>Clarke</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.</article-title>
<source>Syst Rev</source>. <year>2015</year>;<volume>4</volume>:<fpage>1</fpage>.<pub-id pub-id-type="pmid">25554246</pub-id>
</mixed-citation></ref><ref id="R20"><label>[20]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kano</surname><given-names>R</given-names></name><name><surname>Kitagawat</surname><given-names>M</given-names></name><name><surname>Oota</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>First case of feline systemic <italic toggle="yes">Cryptococcus albidus</italic> infection.</article-title>
<source>Med Mycol</source>. <year>2008</year>;<volume>46</volume>:<fpage>75</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">17885946</pub-id>
</mixed-citation></ref><ref id="R21"><label>[21]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poth</surname><given-names>T</given-names></name><name><surname>Seibold</surname><given-names>M</given-names></name><name><surname>Werckenthin</surname><given-names>C</given-names></name><name><surname>Hermanns</surname><given-names>W</given-names></name></person-group>. <article-title>First report of a <italic toggle="yes">Cryptococcus magnus</italic> infection in a cat.</article-title>
<source>Med Mycol</source>. <year>2010</year>;<volume>48</volume>:<fpage>1000</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">20513171</pub-id>
</mixed-citation></ref><ref id="R22"><label>[22]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krumholz</surname><given-names>RA</given-names></name></person-group>. <article-title>Pulmonary cryptococcosis. A case due to <italic toggle="yes">Cryptococcus albidus</italic>.</article-title>
<source>Am Rev Respir Dis</source>. <year>1972</year>;<volume>105</volume>:<fpage>421</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">5011671</pub-id>
</mixed-citation></ref><ref id="R23"><label>[23]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wells</surname><given-names>GM</given-names></name><name><surname>Gajjar</surname><given-names>A</given-names></name><name><surname>Pearson</surname><given-names>TA</given-names></name><name><surname>Hale</surname><given-names>KL</given-names></name><name><surname>Shenep</surname><given-names>JL</given-names></name></person-group>. <article-title>Brief report. Pulmonary cryptosporidiosis and <italic toggle="yes">Cryptococcus albidus</italic> fungemia in a child with acute lymphocytic leukemia.</article-title>
<source>Med Pediatr Oncol</source>. <year>1998</year>;<volume>31</volume>:<fpage>544</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">9835915</pub-id>
</mixed-citation></ref><ref id="R24"><label>[24]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez-Leguizamon</surname><given-names>G</given-names></name><name><surname>Coque-Burgos</surname><given-names>E</given-names></name><name><surname>Espitia-Castro</surname><given-names>O</given-names></name><name><surname>Firacative</surname><given-names>C</given-names></name></person-group>. <article-title>Fatal fungaemia due to <italic toggle="yes">Cryptococcus albidus</italic> in an elderly diabetic woman presenting with pleural effusion.</article-title>
<source>Rev Inst Med Trop Sao Paulo</source>. <year>2020</year>;<volume>62</volume>:<fpage>e34</fpage>.<pub-id pub-id-type="pmid">32491141</pub-id>
</mixed-citation></ref><ref id="R25"><label>[25]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>VF</given-names></name><name><surname>Funari</surname><given-names>AP</given-names></name><name><surname>Taborda</surname><given-names>M</given-names></name><name><surname>Magri</surname><given-names>ASGK</given-names></name><name><surname>Levin</surname><given-names>AS</given-names></name><name><surname>Magri</surname><given-names>MMC</given-names></name></person-group>. <article-title>Cutaneous Naganishia albida (<italic toggle="yes">Cryptococcus albidus</italic>) infection: a case report and literature review.</article-title>
<source>Rev Inst Med Trop Sao Paulo</source>. <year>2023</year>;<volume>65</volume>:<fpage>e60</fpage>.<pub-id pub-id-type="pmid">38055378</pub-id>
</mixed-citation></ref><ref id="R26"><label>[26]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tunkel</surname><given-names>AR</given-names></name><name><surname>Hasbun</surname><given-names>R</given-names></name><name><surname>Bhimraj</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>2017 Infectious diseases society of America&#x02019;s clinical practice guidelines for healthcare-associated ventriculitis and meningitis.</article-title>
<source>Clin Infect Dis</source>. <year>2017</year>;<volume>64</volume>:<fpage>e34</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="pmid">28203777</pub-id>
</mixed-citation></ref><ref id="R27"><label>[27]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales-Lopez</surname><given-names>SE</given-names></name><name><surname>Garcia-Effron</surname><given-names>G</given-names></name></person-group>. <article-title>Infections due to rare cryptococcus species. A literature review.</article-title>
<source>J Fungi (Basel)</source>. <year>2021</year>;<volume>7</volume>:<fpage>279</fpage>.<pub-id pub-id-type="pmid">33917243</pub-id>
</mixed-citation></ref><ref id="R28"><label>[28]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorneanu</surname><given-names>O</given-names></name><name><surname>Filip</surname><given-names>O</given-names></name><name><surname>Miftode</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Cryptococcus meningitis, five years of experience and literature review.</article-title>
<source>Rev Med Chir Soc Med Nat Iasi</source>. <year>2008</year>;<volume>112</volume>:<fpage>100</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="pmid">18677910</pub-id>
</mixed-citation></ref><ref id="R29"><label>[29]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marr</surname><given-names>KA</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Spec</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>A multicenter, longitudinal cohort study of cryptococcosis in human immunodeficiency virus-negative people in the United States.</article-title>
<source>Clin Infect Dis</source>. <year>2020</year>;<volume>70</volume>:<fpage>252</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="pmid">30855688</pub-id>
</mixed-citation></ref><ref id="R30"><label>[30]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Utz</surname><given-names>JP</given-names></name><name><surname>Garriques</surname><given-names>IL</given-names></name><name><surname>Sande</surname><given-names>MA</given-names></name><etal/></person-group>. <article-title>Therapy of cryptococcosis with a combination of flucytosine and amphotericin B.</article-title>
<source>J Infect Dis</source>. <year>1975</year>;<volume>132</volume>:<fpage>368</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="pmid">1185007</pub-id>
</mixed-citation></ref><ref id="R31"><label>[31]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>JE</given-names></name><name><surname>Dismukes</surname><given-names>WE</given-names></name><name><surname>Duma</surname><given-names>RJ</given-names></name><etal/></person-group>. <article-title>A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis.</article-title>
<source>N Engl J Med</source>. <year>1979</year>;<volume>301</volume>:<fpage>126</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="pmid">449951</pub-id>
</mixed-citation></ref><ref id="R32"><label>[32]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>SC</given-names></name></person-group>; <collab>Australasian Society for Infectious Diseases (ASID) Mycoses Iterest Group</collab>. <article-title>Cryptococcosis in Australasia and the treatment of cryptococcal and other fungal infections with liposomal amphotericin B.</article-title>
<source>J Antimicrob Chemother</source>. <year>2002</year>;<volume>49</volume>(<issue>Suppl 1</issue>):<fpage>57</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="pmid">11801583</pub-id>
</mixed-citation></ref><ref id="R33"><label>[33]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamill</surname><given-names>RJ</given-names></name><name><surname>Sobel</surname><given-names>JD</given-names></name><name><surname>El-Sadr</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety.</article-title>
<source>Clin Infect Dis</source>. <year>2010</year>;<volume>51</volume>:<fpage>225</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="pmid">20536366</pub-id>
</mixed-citation></ref><ref id="R34"><label>[34]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Day</surname><given-names>JN</given-names></name><name><surname>Chau</surname><given-names>TT</given-names></name><name><surname>Lalloo</surname><given-names>DG</given-names></name></person-group>. <article-title>Combination antifungal therapy for cryptococcal meningitis.</article-title>
<source>N Engl J Med</source>. <year>2013</year>;<volume>368</volume>:<fpage>2522</fpage>&#x02013;<lpage>3</lpage>.</mixed-citation></ref><ref id="R35"><label>[35]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kordossis</surname><given-names>T</given-names></name><name><surname>Avlami</surname><given-names>A</given-names></name><name><surname>Velegraki</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>First report of <italic toggle="yes">Cryptococcus laurentii</italic> meningitis and a fatal case of <italic toggle="yes">Cryptococcus albidus</italic> cryptococcaemia in AIDS patients.</article-title>
<source>Med Mycol</source>. <year>1998</year>;<volume>36</volume>:<fpage>335</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">10075504</pub-id>
</mixed-citation></ref><ref id="R36"><label>[36]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mccurdy</surname><given-names>LH</given-names></name><name><surname>Morrow</surname><given-names>JD</given-names></name></person-group>. <article-title>Ventriculitis due to <italic toggle="yes">Cryptococcus uniguttulatus</italic>.</article-title>
<source>South Med J</source>. <year>2001</year>;<volume>94</volume>:<fpage>65</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">11213945</pub-id>
</mixed-citation></ref><ref id="R37"><label>[37]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rimek</surname><given-names>D</given-names></name><name><surname>Haase</surname><given-names>G</given-names></name><name><surname>L&#x000fc;ck</surname><given-names>A</given-names></name><name><surname>Casper</surname><given-names>J</given-names></name><name><surname>Podbielski</surname><given-names>A</given-names></name></person-group>. <article-title>First report of a case of meningitis caused by <italic toggle="yes">Cryptococcus adeliensis</italic> in a patient with acute myeloid leukemia.</article-title>
<source>J Clin Microbiol</source>. <year>2004</year>;<volume>42</volume>:<fpage>481</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="pmid">14715811</pub-id>
</mixed-citation></ref><ref id="R38"><label>[38]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conde-Pereira</surname><given-names>C</given-names></name><name><surname>Rodas-Rodr&#x000ed;guez</surname><given-names>L</given-names></name><name><surname>D&#x000ed;az-Paz</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Fatal case of polymicrobial meningitis caused by cryptococcus liquefaciens and mycobacterium tuberculosis complex in a human immunodeficiency virus-infected patient.</article-title>
<source>J Clin Microbiol</source>. <year>2015</year>;<volume>53</volume>:<fpage>2753</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">26019205</pub-id>
</mixed-citation></ref><ref id="R39"><label>[39]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Animalu</surname><given-names>C</given-names></name><name><surname>Mazumder</surname><given-names>S</given-names></name><name><surname>Cleveland</surname><given-names>KO</given-names></name><name><surname>Gelfand</surname><given-names>MS</given-names></name></person-group>. <article-title><italic toggle="yes">Cryptococcus uniguttulatus</italic> meningitis.</article-title>
<source>Am J Med Sci</source>. <year>2015</year>;<volume>350</volume>:<fpage>421</fpage>&#x02013;<lpage>2</lpage>.<pub-id pub-id-type="pmid">26371608</pub-id>
</mixed-citation></ref><ref id="R40"><label>[40]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nematollahi</surname><given-names>S</given-names></name><name><surname>Dioverti-Prono</surname><given-names>V</given-names></name></person-group>. <article-title>Cryptococcal infection in haematologic malignancies and haematopoietic stem cell transplantation.</article-title>
<source>Mycoses</source>. <year>2020</year>;<volume>63</volume>:<fpage>1033</fpage>&#x02013;<lpage>46</lpage>.<pub-id pub-id-type="pmid">32740974</pub-id>
</mixed-citation></ref><ref id="R41"><label>[41]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugita</surname><given-names>T</given-names></name><name><surname>Takashima</surname><given-names>M</given-names></name><name><surname>Ikeda</surname><given-names>R</given-names></name><name><surname>Nakase</surname><given-names>T</given-names></name><name><surname>Shinoda</surname><given-names>T</given-names></name></person-group>. <article-title>Intraspecies diversity of <italic toggle="yes">Cryptococcus albidus</italic> isolated from humans as revealed by sequences of the internal transcribed spacer regions.</article-title>
<source>Microbiol Immunol</source>. <year>2001</year>;<volume>45</volume>:<fpage>291</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">11386419</pub-id>
</mixed-citation></ref><ref id="R42"><label>[42]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heckler</surname><given-names>C</given-names></name><name><surname>Vale</surname><given-names>MG</given-names></name><name><surname>Canales</surname><given-names>HDS</given-names></name><etal/></person-group>. <article-title>Spore-forming bacteria in gelatin: Characterization, identification by 16S rRNA and MALDI-TOF mass spectrometry (MS), and presence of heat resistance and virulence genes.</article-title>
<source>Int J Food Microbiol</source>. <year>2024</year>;<volume>422</volume>:<fpage>110813</fpage>.<pub-id pub-id-type="pmid">38970997</pub-id>
</mixed-citation></ref><ref id="R43"><label>[43]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaumeau</surname><given-names>V</given-names></name><name><surname>Piarroux</surname><given-names>M</given-names></name><name><surname>Kulabkeeree</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Identification of Southeast Asian Anopheles mosquito species using MALDI-TOF mass spectrometry.</article-title>
<source>PLoS One</source>. <year>2024</year>;<volume>19</volume>:<fpage>e0305167</fpage>.<pub-id pub-id-type="pmid">38968228</pub-id>
</mixed-citation></ref><ref id="R44"><label>[44]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eigner</surname><given-names>U</given-names></name><name><surname>Holfelder</surname><given-names>M</given-names></name><name><surname>Oberdorfer</surname><given-names>K</given-names></name><name><surname>Betz-Wild</surname><given-names>U</given-names></name><name><surname>Bertsch</surname><given-names>D</given-names></name><name><surname>Fahr</surname><given-names>A-M</given-names></name></person-group>. <article-title>Performance of a matrix-assisted laser desorption ionization-time-of-flight mass spectrometry system for the identification of bacterial isolates in the clinical routine laboratory.</article-title>
<source>Clin Lab</source>. <year>2009</year>;<volume>55</volume>:<fpage>289</fpage>&#x02013;<lpage>96</lpage>.<pub-id pub-id-type="pmid">19894408</pub-id>
</mixed-citation></ref><ref id="R45"><label>[45]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ragupathi</surname><given-names>L</given-names></name><name><surname>Reyna</surname><given-names>M</given-names></name></person-group>. <article-title>Case report of <italic toggle="yes">Cryptococcus albidus</italic> peritonitis in a peritoneal dialysis patient and a review of the literature.</article-title>
<source>Perit Dial Int</source>. <year>2015</year>;<volume>35</volume>:<fpage>421</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">24584615</pub-id>
</mixed-citation></ref><ref id="R46"><label>[46]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arendrup</surname><given-names>MC</given-names></name><name><surname>Boekhout</surname><given-names>T</given-names></name><name><surname>Akova</surname><given-names>M</given-names></name><name><surname>Meis</surname><given-names>JF</given-names></name><name><surname>Cornely</surname><given-names>OA</given-names></name><name><surname>Lortholary</surname><given-names>O</given-names></name></person-group>. <article-title>ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections.</article-title>
<source>Clin Microbiol Infect</source>. <year>2014</year>;<volume>20</volume>(<issue>Suppl 3</issue>):<fpage>76</fpage>&#x02013;<lpage>98</lpage>.</mixed-citation></ref><ref id="R47"><label>[47]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horowitz</surname><given-names>ID</given-names></name><name><surname>Blumberg</surname><given-names>EA</given-names></name><name><surname>Krevolin</surname><given-names>L</given-names></name></person-group>. <article-title><italic toggle="yes">Cryptococcus albidus</italic> and mucormycosis empyema in a patient receiving hemodialysis.</article-title>
<source>South Med J</source>. <year>1993</year>;<volume>86</volume>:<fpage>1070</fpage>&#x02013;<lpage>2</lpage>.<pub-id pub-id-type="pmid">8367759</pub-id>
</mixed-citation></ref></ref-list></back></article>